ESC Premium Access

Scenario 2 - Neprilysin inhibitors in heart failure: safety and adverse events

Congress Session

About the speaker

Assistant Professor Marta Izabela Kaluzna-Oleksy

Poznan University of Medical Sciences, Poznan (Poland)
4 presentations
0 follower

5 more presentations in this session

Safety first: avoiding adverse events with new cardiovascular drugs - Panel

Thumbnail

Introduction - Safety first: avoiding adverse events with new cardiovascular drugs

Speaker: Doctor M. Alonso Garcia (London, GB)

Thumbnail

Scenario 1 - Adverse events of new lipid lowering drugs.

Speaker: Doctor T. Hall (Oslo, NO)

Thumbnail

Scenario 3 - Long-term safety of new anti-diabetic drugs.

Speaker: Associate Professor A. Niessner (Vienna, AT)

Thumbnail

Safety first: avoiding adverse events with new cardiovascular drugs - Take Home Message.

Speaker: Professor J. Tamargo (Madrid, ES)

Thumbnail

Access the full session

Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs

Speakers: Assistant Professor M. Kaluzna-Oleksy, Doctor M. Alonso Garcia, Doctor T. Hall, Associate Professor A. Niessner, Professor J. Tamargo
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk